Medication info

Aprogen Ranitidine Tablet 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Aprogen BioLogic Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 199500687 · Notified 1995.05.24

This product's status changed to Approval withdrawn on 2024.01.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, reflux esophagitis, etc.) and improvement of gastric mucosal lesions; prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is also advisable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients aged 12 years and older, administer 75 mg of this drug orally twice daily (liquid formulation only). For patients aged 8 〜 18 years, 150 mg (2 mg/kg body weight) may be administered up to twice daily.

Ingredients

Manufacturer
Aprogen BioLogic Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, reflux esophagitis, etc.) and improvement of gastric mucosal lesions; prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • prevention of Mendelson syndrome
  • post-operative ulcers
  • gastric and duodenal ulcers due to NSAID use
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal redness
  • gastric mucosal swelling
  • acute gastritis
  • exacerbation of chronic gastritis
View approved original text

This medication is used for gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson syndrome before anesthesia and treating post-operative ulcers, as well as preventing ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps improve gastric mucosal lesions due to acute and chronic gastritis exacerbation, as well as upper gastrointestinal bleeding. It is also used to relieve symptoms of heartburn and acid regurgitation caused by excess gastric acid. This drug improves symptoms by protecting the gastric mucosa and inhibiting gastric acid secretion.

How to take

Adult dose

Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is also advisable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients aged 12 years and older, administer 75 mg of this drug orally twice daily (liquid formulation only). For patients aged 8 〜 18 years, 150 mg (2 mg/kg body weight) may be administered up to twice daily.

Precautions

This medication should not be used by those who have had an allergic reaction to this drug or its components. Additionally, it should not be administered to patients with a history of acute porphyria, as it may worsen their symptoms. Since this drug contains lactose, it cannot be used in patients with genetic disorders that prevent lactose digestion. Patients with poor kidney function should use this medication cautiously, as the rate of clearance may be slowed, and dosage should be reduced or the dosing interval increased. Patients with impaired liver function should also use it carefully, and those with a previous drug allergy should use it cautiously. Elderly patients may have a higher risk of side effects; therefore, special caution is required. Those taking NSAIDs may encounter gastrointestinal problems, so regular check-ups are necessary. This drug may mask symptoms of stomach cancer; therefore, if gastric ulcer patients or those over middle age develop new or changed dyspeptic symptoms, malignancy should be ruled out before use. Helicobacter pylori-positive gastric and duodenal ulcer patients should undergo treatment to eliminate this bacterium. Severe allergic reactions or shock may rarely occur when taking this medication, so if any unusual symptoms appear, discontinue immediately and consult a healthcare professional. Hypersensitivity reactions such as urticaria, rash, or difficulty breathing may occur; if such symptoms arise, stop taking the drug. Blood-related issues may lead to decreased white blood cell or platelet counts, and if fatigue or bleeding occurs, immediate testing is necessary. Liver function may transiently deteriorate, so if jaundice or fatigue appears, treatment should be stopped. Cardiovascular abnormalities such as arrhythmias or vasculitis have also been reported rarely, so caution is advised. Gastrointestinal symptoms may include constipation, nausea, abdominal pain, among others, and acute pancreatitis may occur rarely. Neurological side effects such as dizziness, drowsiness, confusion, or depression may appear; thus, close observation is necessary if unusual symptoms occur. This drug may interact with other medications, so if you're taking other medicines, you must inform your healthcare provider. In particular, when used with drugs affecting blood clotting, frequent blood tests are necessary to monitor the condition. The effect of some drugs taken with this medication may change, so it may be necessary to adjust the dosing interval or dosage. Women who are pregnant or may become pregnant should use this drug cautiously, as its safety is not established; use should be reserved for necessary situations. If breastfeeding, this drug can pass into breast milk, so it should only be given if necessary. There is little experience using this drug in children, so safety has not been established. Elderly patients should use this drug carefully, as reduced kidney function may allow the medication to remain in the body longer; thus, adjusting the dose and interval is recommended. Dizziness or drowsiness may occur when taking this drug; therefore, it is advisable to avoid driving or operating hazardous machinery. No serious issues have been reported with overdose; however, proper treatment such as vomiting or gastric lavage may be necessary. Keep this drug out of the reach of children, and avoid transferring it to other containers as it may alter its quality. This drug may reduce gastric acid secretion, promoting bacterial growth in the stomach; therefore, regular check-ups, including eye examinations, are necessary when used for long periods.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 59 more
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • systemic malaise
  • weakness
  • subcutaneous hemorrhage
  • submucosal hemorrhage
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • appetite loss
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • muscular cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container that blocks light, maintaining a temperature between 1 and 30 degrees Celsius (room temperature). This is an important storage method to preserve the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.